This is in line with findings from breast, lung, thyroid, and urothelial cancer; moreover, our own group reported strong PSMA expression in tumor-associated neovasculature of a significant percentage of rhabdomyosarcomas, malignant peripheral nerve sheath tumors, synovial sarcomas, and undifferentiated pleomorphic sarcomas [18]. Here, FOLH1 is linked to undifferentiated pleomorphic sarcoma.